54% of Americans Want Daylight Saving Time Ended
As the annual "spring forward" to observe daylight saving time approaches on March 9, new Gallup polling data reveals a majority of Americans want to eliminate the practice.
As the annual "spring forward" to observe daylight saving time approaches on March 9, new Gallup polling data reveals a majority of Americans want to eliminate the practice.
As the annual “spring forward” to observe daylight saving time approaches on March 9, new Gallup polling data reveals a majority of Americans want to eliminate the practice.
Read MoreResults from ResMed’s fifth annual Global Sleep Study reveal the toll that poor sleep takes on health, work, and relationships.
Read MoreIn a clinical trial, 95% of participants reported better sleep in four weeks.
Read MoreThe digital therapeutic uses cognitive behavioral therapy to treat chronic insomnia in adults, with clinical trials showing up to 76% efficacy.
Read MoreThe European Medicines Agency’s CHMP recommended expanding the use of a melatonin-based treatment to help children with neurogenetic disorders manage insomnia.
Read MoreNew Jersey-based Cosette Pharmaceuticals has acquired the insomnia medications Ambien and Ambien CR from Sanofi US.
Read MoreWhen given with morphine, the insomnia drug prevented addiction in mice while maintaining effective pain relief.
Read MoreAsthmatics with insomnia experienced more asthma exacerbations than those without insomnia and were more likely to have concurrent sleep apnea, along with anxiety or depression.
Read MoreThe trials will investigate potential treatments for long COVID-related sleep disturbances, exercise intolerance, and post-exertional malaise.
Read MoreA study examined the comparative effects of specific exercises on sleep quality in patients with advanced lung cancer, finding one method particularly effective.
Read MoreA survey of people who had been diagnosed with COVID-19 but never hospitalized found that 76% developed insomnia—and anxious or depressed people were more vulnerable.
Read MoreSimple breathing exercises done twice daily while using a mobile phone app can help relieve the symptoms of long COVID.
Read MoreSleep tracking app Sleep Cycle analyzed over 2 million hours of sleep to understand how coughing may be affecting users’ sleep health.
Read MoreThe device is designed to improve insomnia by delivering a small electrical pulse to the head for 30 minutes before bed.
Read MoreHealth Care Originals, a maker of cardiopulmonary wearable systems, acquired Dawn Health’s virtual sleep care platform to accelerate the deployment of its Nightingale virtual care to benefit Americans with asthma or COPD.
Read MoreA study involving over 600,000 participants revealed a significantly elevated risk of respiratory infection among individuals diagnosed with insomnia.
Read MoreNew research examines the mortality and exacerbation risks associated with non-benzodiazepine benzodiazepine receptor agonists versus other hypnotics to treat insomnia in COPD patients.
Read MoreResearchers determined the extent to which individuals with poor sleep quality and high genetic susceptibility to asthma were at a greater risk of developing the condition compared to those with a healthy sleep pattern and low genetic risk.
Read MoreHow strongly a vaccine protects you may depend on getting enough sleep in the days before and after inoculation, according to a new meta-analysis examining the relationship between sleep duration and the body’s response to vaccination.
Read MoreSleeping less than five hours a night is associated with a 74% raised likelihood of developing peripheral artery disease (PAD) compared with seven to eight hours of sleep.
Read MoreInsomnia is present in nearly half of heart disease patients, according to research presented at ESC 2022 and published in SLEEP Advances.
Read MoreNew research from the American Heart Association revealed beta-blockers were not more likely to cause depression compared to other similar treatments, but the drugs may be linked to unusual dreams, insomnia and sleep disorders.
Read MoreThe US FDA has approved the orexin receptor antagonist Dayvigo (lemborexant) for the treatment of insomnia, according to manufacturer Eisai Co Ltd.
Read MoreAdolescents diagnosed with insomnia have a high prevalence of concurrent mental health disorders...
Read More